TipRanks
Go Ultimate55% OFF

Genetec Corp. (4492) Stock Price & Analysis

4492 Stock Chart & Stats

¥353.00-¥11.00(-3.02%)
At close: 3:30 PM GMT+9
¥360¥380¥4003 Aug17 Aug31 Aug14 Sep28 Sep13 Oct26 Oct
Day’s Range
JPY 362.00 - JPY 368.00
52-Week Range
JPY 345.00 - JPY 499.00
Previous Close
JPY 364.00
Volume
N/A
Average Volume (3M)
14.06K
Market Cap
JPY 4.22B
Enterprise Value
JPY 4.90B
Total Cash (Recent Filing)
JPY 1.59B
Total Debt (Recent Filing)
JPY 1.82B
Price to Earnings (P/E)
8.4
Beta
0.32
Next Earnings
Nov 13, 2026 (Est.)
EPS Estimate
N/A
Dividend Yield
5.22%

Bulls Say, Bears Say

Bulls Say

Accelerating Revenue Growth

The acceleration in revenue growth indicates strengthening demand and expanding business activity. If sustained, it can improve operating leverage, support continued investment in software offerings, and reinforce the company’s market position over the next several quarters.

Sustained Profitability

The move from near-breakeven performance to healthy operating and net margins demonstrates improved earnings capacity. Sustained profitability provides internal funding for product development and operations, although future margin stability remains important.

Improved Shareholder Returns

ROE of roughly 18–19% across three years indicates stronger earnings generation from shareholder capital than in earlier periods. This supports the view that the business has improved its underlying profitability and capital-use effectiveness.

Bears Say

Sharp Cash-Flow Deterioration

The latest collapse in operating and free cash flow, alongside very low cash conversion, raises concern that reported earnings are not translating into liquidity. Working-capital volatility or collection pressure could constrain reinvestment and financial resilience.

Higher Leverage

Leverage has increased materially from the company’s historically low-debt profile, reducing financial flexibility. Higher debt can amplify pressure on cash resources and limit the company’s ability to absorb weaker cash generation or fund growth through downturns.

Easing Profit Margins

Margin compression despite strong revenue growth suggests rising costs, investment requirements, or a less favorable sales mix. If persistent, it could limit operating leverage and reduce the earnings benefit from continued expansion in the software business.

4492 FAQ

What was Genetec Corp.’s price range in the past 12 months?
Genetec Corp. lowest stock price was ¥345.00 and its highest was ¥499.00 in the past 12 months.
What is Genetec Corp.’s market cap?
Genetec Corp.’s market cap is ¥4.22B.
When is Genetec Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genetec Corp.’s earnings last quarter?
Genetec Corp. released its earnings results on Aug 07, 2026. The company reported ¥0.36 earnings per share for the quarter.
Is Genetec Corp. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Genetec Corp. pay dividends?
Genetec Corp. pays a Semiannually dividend of ¥7.5 which represents an annual dividend yield of 5.22%. See more information on Genetec Corp. dividends here
What is Genetec Corp.’s EPS estimate?
Genetec Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genetec Corp. have?
Genetec Corp. has 11,741,900 shares outstanding.
What happened to Genetec Corp.’s price movement after its last earnings report?
Genetec Corp. reported an EPS of ¥0.36 in its last earnings report. Following the earnings report the stock price went down -5.542%.
Which hedge fund is a major shareholder of Genetec Corp.?
Currently, no hedge funds are holding shares in JP:4492
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology